Avadel Pharmaceuticals and the American Academy of Sleep Medicine Foundation Announce an Exclusive Collaboration on the 2022 Young Investigators Research Forum
03 6월 2022 - 9:00PM
Avadel Pharmaceuticals plc (Nasdaq: AVDL), a biopharmaceutical
company focused on transforming medicines to transform lives,
announced today that it entered into an exclusive collaboration
with the American Academy of Sleep Medicine (AASM) Foundation, to
support its 2022 Young Investigators Research Forum (YIRF),
providing scholarships and research training to early career sleep
medicine researchers.
The Young Investigators Research Forum is a unique annual
training program that was first launched in 2009, providing
guidance, tactics, and strategies to better position early career
investigators for a successful career in sleep research. The
program aims to provide trainees with the necessary skills for a
productive and successful career, including refining research
ideas, understanding grant funding opportunities, and establishing
extramural networking and mentorship with other early career
investigators, established senior investigators, as well as with
scientific and program officers from federal funding agencies.
“Our continued partnership with the AASM Foundation on this
critical research program supporting up-and-coming sleep scientists
represents a shared goal to advance sleep research for the benefit
of patients,” said Jennifer Gudeman, PharmD, Vice President,
Medical and Clinical Affairs at Avadel. “A natural, restorative
sleep-wake cycle is fundamental for good physical and mental
health. We understand that having a disordered sleep condition,
like narcolepsy, is disruptive to all facets of life, which is why
we’re passionate about prioritizing relationships with patients,
healthcare professionals and the broader sleep community, to
identify the real needs of patients and to find better ways to
serve them.”
AASM Foundation President Anita V. Shelgikar, MD, MHPE added,
“We thank Avadel for their continued support of early career sleep
researchers and their sponsorship of the 2022 Young Investigators
Research Forum. Avadel’s contributions to the AASM Foundation
support the sleep research community and the patients we serve by
allowing us to create new grant programs to work toward healthier
lives through better sleep.”
The Young Investigators Research Forum continues in June with a
special engagement at the upcoming 36th Annual Meeting of the
Associated Professional Sleep Societies (APSS), the joint meeting
of the American Academy of Sleep Medicine (ASSM) and the Sleep
Research Society, also known as SLEEP 2022, being held from June
4-8, 2022 in Charlotte, NC. Avadel’s exclusive sponsorship of YIRF
continues with the company’s participation in the 2022 AASM
Foundation, YIRF and Sleep Research Program for Advancing Careers
(SOAR) Networking Lunch. The lunch will take place on Monday, June
6, 2022 from 12:30 – 1:45pm ET at The Westin Charlotte.
To learn more about the Young Investigators Research Forum,
please visit:
https://foundation.aasm.org/award-programs/young-investigators-research-forum/
About Avadel Pharmaceuticals plcAvadel
Pharmaceuticals plc (Nasdaq: AVDL) is a biopharmaceutical company
focused on transforming medicines to transform lives. Our approach
includes applying innovative solutions to the development of
medications that address the challenges patients face with current
treatment options. Our current lead drug candidate, FT218, is an
investigational formulation of sodium oxybate leveraging our
proprietary drug delivery technology and designed to be taken once
at bedtime for the treatment of EDS and cataplexy in adults with
narcolepsy. For more information, please visit www.avadel.com.
About the American Academy of Sleep Medicine
Foundation:Founded in 1998, the AASM Foundation is a
not-for-profit 501(c)(3) charitable and scientific organization
that was established by the American Academy of Sleep
Medicine. The AASM Foundation has invested in the future of sleep
medicine by supporting more than 270 awards totaling $21 million in
funding. The AASM Foundation’s portfolio includes research awards
for all career stages, community awards and training awards. For
more information, please visit foundation.aasm.org.
Investor Contact:Courtney TurianoStern Investor
Relations, Inc. Courtney.Turiano@sternir.com (212) 698-8687
Media Contact:Nicole Raisch GoelzReal
Chemistryngoelz@realchemistry.com(408) 568-4292
AASM Foundation Media Contact:media@aasm.org
(630) 737-9700
Avadel Pharmaceuticals (NASDAQ:AVDL)
과거 데이터 주식 차트
부터 6월(6) 2024 으로 7월(7) 2024
Avadel Pharmaceuticals (NASDAQ:AVDL)
과거 데이터 주식 차트
부터 7월(7) 2023 으로 7월(7) 2024